Metabolikusan nem megítélhető
English translation: metabolic activity cannot be confirmed, CT recommended
| GLOSSARY ENTRY (DERIVED FROM QUESTION BELOW) | ||||||
|---|---|---|---|---|---|---|
|
| 13:49 Feb 22, 2016 |
| Hungarian to English translations [PRO] Medical - Medical (general) | |||||||
|---|---|---|---|---|---|---|---|
|
| ||||||
|  Selected response from: Attila Cselenyák Hungary Local time: 18:12 | ||||||
Grading comment
| |||||||
| Summary of answers provided | ||||
|---|---|---|---|---|
| 4 +1 | metabolic activity cannot be confirmed, CT recommended |
| ||
| 4 +1 | Ld.lent |
|
| Discussion entries: 3 | |
|---|---|
Answers
37 mins confidence: 
peer agreement (net): +1
peer agreement (net): +1metabolic activity cannot be confirmed, CT recommended Explanation: https://en.wikipedia.org/wiki/Positron_emission_tomography PET scanning with the tracer fluorine-18 (F-18) fluorodeoxyglucose (FDG), called FDG-PET, is widely used in clinical oncology. This tracer is a glucose analog that is taken up by glucose-using cells and phosphorylated by hexokinase (whose mitochondrial form is greatly elevated in rapidly growing malignant tumours). A typical dose of FDG used in an oncological scan has an effective radiation dose of 14 mSv.[3] Because the oxygen atom that is replaced by F-18 to generate FDG is required for the next step in glucose metabolism in all cells, no further reactions occur in FDG. Furthermore, most tissues (with the notable exception of liver and kidneys) cannot remove the phosphate added by hexokinase. This means that FDG is trapped in any cell that takes it up, until it decays, since phosphorylated sugars, due to their ionic charge, cannot exit from the cell. This results in intense radiolabeling of tissues with high glucose uptake, such as the brain, the liver, and most cancers. As a result, FDG-PET can be used for diagnosis, staging, and monitoring treatment of cancers, particularly in Hodgkin's lymphoma, non-Hodgkin lymphoma, and lung cancer. Many other types of solid tumors will be found to be very highly labeled on a case-by-case basis—a fact that becomes especially useful in searching for tumor metastasis, or for recurrence after a known highly active primary tumor is removed. Because individual PET scans are more expensive than "conventional" imaging with computed tomography (CT) and magnetic resonance imaging (MRI), expansion of FDG-PET in cost-constrained health services will depend on proper health technology assessment; this problem is a difficult one because structural and functional imaging often cannot be directly compared, as they provide different information. Oncology scans using FDG make up over 90% of all PET scans in current practice[citation needed]. A few other isotopes and radiotracers are slowly being introduced into oncology for specific purposes. For example, 11C-labelled metomidate (11C-metomidate), has been used to detect tumors of adrenocortical origin.[4][5] Also, FDOPA PET-CT, in centers which offer it, has proven to be a more sensitive alternative to finding, and also localizing, pheochromocytoma than the MIBG scan.[6][7][8] magyarul itt: http://www.citymed.hu/cikkreszletes.php?actmenu=5&actsubmenu... Reference: http://www.citymed.hu/cikkreszletes.php?actmenu=5&actsubmenu... Reference: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1255942/ |
| |||||||||||||
Grading comment
| ||||||||||||||
1 hr confidence: peer agreement (net): +1
Login or register (free and only takes a few minutes) to participate in this question. You will also have access to many other tools and opportunities designed for those who have language-related jobs (or are passionate about them). Participation is free and the site has a strict confidentiality policy. KudoZ™ translation helpThe KudoZ network provides a framework for translators and others to assist each other with translations or explanations of terms and short phrases.
See also: Search millions of term translations Your current localization setting
English
Select a language Close search
| ||||||||||||||
